<DOC>
	<DOCNO>NCT02557074</DOCNO>
	<brief_summary>In prospective pilot study investigator show low dos IL2 could beneficial severe AA inducing long lasting regrowth 4 5 patient treat . The objective study compare long term efficacy low dos IL2 versus placebo multicenter prospective randomize double blind study .</brief_summary>
	<brief_title>TREg Activation Treatment PELADE ( Alopecia Areata )</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Of 18 year old , Affiliated social security system , Clinical diagnosis alopecia areata , 50 % surface scalp affect Last flaire start less one year Alopecia areata resist least 1 systematic treatment include phototherapy ( UVB PUVA ) , general corticosteroid therapy methotrexate Signature inform consent Pregnancy refusal contraception woman old enough procreate , Refusal contraception men Local treatment ( dermocorticoïdes , minoxidil ) systematism ( oral corticosteroid therapy , méthotrexate immunosuppresseur ) since less 2 less , Evolutionary autoimmune cancer disease forgiveness Excessive grip ( take ) alcohol ( upper 3 glass wine day one prelunch drink day ) Seropositivity VHC , VHB , HIV Patient present severe renal and/or hepatic insufficiency , Presenting patient one zone , chicken pox , herpes , tuberculosis , evolutionary infectious disease , respiratory failure … Vulnerable person ( nobody guardianship minor ( miner ) , adult , deprive freedom ) IC treatment ( process ) IL2R Presenting contraindication ProleukinR</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>